Heta nyheter
Få 50% rabatt 0
Lås upp premiumdata: Upp till 50% rabatt InvestingPro HÄMTA REA
Stäng

Bny Mellon Large Cap Securities Inc (DREVX)

Skapa bevakning
New!
Skapa bevakning
Webbsida
  • Som ett varningsmeddelande
  • För att använda funktionen, se till att du är inloggad på ditt konto
Mobil app
  • För att använda funktionen, se till att du är inloggad på ditt konto
  • Se till att du är inloggad med samma användarprofil

Villkor

Frekvens

En gång
%

Frekvens

Frekvens

Leveransmetod

Status

Lägg till/Ta bort från en portfölj Lägg till portföljen
Lägg till på bevakningslistan
Lägg till position

Position har lagts till i:

Namnge din innehavsportfölj
 
19,44 -0,12    -0,61%
28/06 - Stängd. Valuta i USD ( Friskrivning )
Typ:  Fond
Marknad:  USA
Utgivare:  Dreyfus
Tillgångsklass:  Aktier
  • Morningstar-värdering:
  • Totala tillgångar: 2,42B
Dreyfus Fund Incorporated 19,44 -0,12 -0,61%

DREVX Översikt

 
På denna sida hittar du en djupgående profil av Bny Mellon Large Cap Securities Inc. Läs om viktig ledning, totala tillgångar, investeringsstrategi och kontaktinformation om DREVX tillsammans med annan information.
Kategori

Large Growth

Totala tillgångar

2,42B

Utgifter

0,69%

Startdatum

18772

Kontaktinformation

Adress 240 Greenwich Street
New York,NY 10286
United States
Telefon -

Verkställande ledning

Namn Titel Sedan Till
Karen Miki Behr - 2021 Nu
Biografi Miki is a member of Newton’s equity opportunities team. In her current role, she is a portfolio manager on the growth funds. Miki joined Newton in September 2021, following the integration of Mellon Investments Corporation’s equity and multi-asset capabilities into the Newton Investment Management Group. Before joining Newton, Miki was a senior research analyst at Mellon Investments Corporation and The Boston Company Asset Management (both BNY Mellon group companies). Previously, she was a research analyst with a focus on healthcare. Over her 14 years at the firm, she covered the consumer staples, consumer discretionary and healthcare sectors across EM, EAFE and the US. Prior to joining BNY Mellon, Miki worked at Leerink Swann & Co., a healthcare investment bank, advising venture capital and private equity firms as well as pharmaceutical, biotech and medical-device companies on strategic growth opportunities.
Julianne D. McHugh Portfolio Manager 2021 Nu
Biografi Julianne is a senior portfolio manager and Newton’s head of sustainable equities. As an experienced investor, she has been integral in identifying resources to support and enhance the integration of sustainability considerations into the firm’s investment practices. Julianne manages a selection of global and regional equity mandates. She is the lead portfolio manager for the BNY Mellon Large Cap Securities Fund, leveraging the global research team to deliver capital growth by investing in high quality US companies with strong positions in their industries. Julianne has led the Emerging Markets Research Fund since its inception in February 2014. She also serves as a portfolio manager for Newton’s Global Research Equity and Global First Decade Innovators strategies. Julianne joined Newton in September 2021, following the integration of Mellon Investments Corporation’s equity and multi-asset capabilities into the Newton Investment Management Group. Before joining Newton, Julianne was a senior portfolio manager and senior research analyst at Mellon Investments Corporation and The Boston Company Asset Management (both BNY Mellon group companies). Prior to joining BNY Mellon, Julianne was an equity analyst at State Street Research & Management. Julianne has a BS in Finance from Lehigh University and an MBA with a Financial Management track from MIT Sloan School of Management.
Matt Jenkin Senior Research Analyst 2020 2023
Biografi Matt is a senior research analyst on The Boston Company's Global Research team, covering the health care sector. He has 15 years of health-care investing experience and almost five years of health-care industry experience. Matt has served as a health care portfolio manager and analyst at Balyasny Asset Management, Lehman Brokers/Barclays Capital and Bluecrest Capital Management, where he managed global long/short equity health-care hedge funds and covered pharmaceuticals, biotechnology and health-care services. He also worked at Dreyfus from 2001 to 2005, where he incepted and managed the 4-star Morningstar-rated Dreyfus Health Care Fund and maintained health-care sector research coverage. Earlier in his career, Matt was a senior research scientist at SmithKline Beecham, where he helped to develop cardiovascular/general surgical techniques, designed surgical models for MRI in stroke research, and researched osteoporosis. Matt earned a bachelor’s degree in biology from Tulane University and an M.B.A. from New York University.
Erik Swords - 2019 2022
Biografi Erik Swords with company 19 years, Industry experience 19 years Erik Swords is a head of global technology strategies on the fundamental thematic team at Voya Investment Management. He joined the firm following Voya’s integration of certain assets and teams comprising the substantial majority of Allianz Global Investors U.S. business, where he was a lead portfolio manager, managing director and led the U.S. global technology team. Prior to that, he worked at Newton Investment Management for 16 years, leading one of BNY Mellon’s largest technology strategies, along with several other thematic portfolios focused on technology and related sectors. Previously, he worked as a research analyst covering the software sector at Pilgrim Baxter Associates, Exis Capital Management and Credit Suisse First Boston Technology Group. Erik earned a BS in finance from Lehigh University.
Leigh N. Todd Managing Director 2015 2021
Biografi Ms. Todd is a managing director and senior research analyst at Mellon Investments Corporation ("Mellon") and joined Mellon's predecessor company in 2005. She was previously employed by Dreyfus, and affiliated BNY Mellon company, since 2001. Prior to that, she was employed by State Street Global Advisors.
Robin Wehbe Director 2019 2020
Biografi Robin Wehbe, CFA, CMT, is a director and equity research analyst at The Boston Company Asset Management, LLC (TBCAM), an affiliate of Dreyfus, where he has been employed since July 2006. He is a research analyst on TBCAM’s core research team, covering the energy, utilities and basic materials sectors. Prior to joining TBCAM, he was employed with State Street Global Advisors since 2003, most recently as a global research analyst, covering the basic materials sector. He also has been employed by Dreyfus since January 2009.
Barry K. Mills Lead Portfolio Manager 2010 2019
Biografi Mills is a portfolio manager and senior managing analyst with Drefyus, his employer since 1999. Prior to joining the firm, he served as a portfolio manager with Phoenix Funds. From 1995-February 1997, he served as Director of Research for Howe and Rusling, Inc.
David M. Sealy Portfolio Manager 2010 2019
Biografi Sealy is a portfolio manager at Dreyfus. He is a vice president, portfolio manager and research analyst at The Boston Company Asset Management, LLC, an affiliate of Dreyfus, where he has been employed since June 2005. He also has been employed by Dreyfus since May 1997.
Elizabeth Slover Director/ Portfolio Manager 2015 2019
Biografi Elizabeth is the Director of The Boston Company’s Global Research Team, overseeing research for the U.S., EAFE and Emerging Markets. Elizabeth is also a Portfolio Manager on the US Large Cap Growth Equity strategy. Before joining The Boston Company, Elizabeth was with Chancellor LGT Asset Management (now Invesco), where she worked for the Director of Equities, responsible for managing the Equity Research Group. Before joining Chancellor, Elizabeth was in the Equity Research Department of Smith Barney, where she worked for the Chief Investment Strategist. She received a BA in Political Science from Union College.
Sean P. Fitzgibbon - 2005 2015
Biografi Sean P. Fitzgibbon, CFA Executive Vice President, Senior Portfolio Manager Sean is the lead portfolio manager for the firm's Thematic Active Equity and Emerging Markets Equity strategies. Previously, he worked in research, covering Health Care, Consumer Discretionary, Consumer Staples, Financials and Utilities. Sean received a BS in economics from Northeastern University and an MBA from Babson College. He holds the CFA® designation and is a member of the CFA Institute and the CFA Society Boston.
Riktlinjer för kommentarer

Vi uppmuntrar dig att använda kommentarer för att engagera dig med andra användare, dela ditt perspektiv och ställa frågor till skribenter och till varandra. Men för att upprätthålla den höga diskursen har vi alla kommit att värdera och förväntar oss att hålla följande kriterier i åtanke:

  • Berika samtalen
  • Vara fokuserad och på rätt spår. Gör endast inlägg som är relevant för ämnet som diskuteras.
  • Var respektfull. Även negativa åsikter kan ramas in på ett positivt och diplomatiskt sätt.
  • Använd standard skrivsätt. Inkludera kommatering, versaler och gemener.
  • NOTERA: Spam och/eller säljfrämjande meddelanden och länkar inom en kommentar kommer att tas bort
  • Undvik svordomar, förtal eller personliga angrepp riktad mot en skribent eller en annan användare.
  • Endast svedese kommentarer kommer att tillåtas.

Ansvariga för spam eller missbruk kommer att tas bort från webbplatsen och förbjudas från framtida registrering på Investing.com diskretion.

DREVX Kommentarer

Skriv dina tankar om Bny Mellon Large Cap Securities Inc
 
Aär du säker på att du vill ta bort det här diagrammet?
 
Posta
Publicera även på :
 
Ersätt det bifogade diagrammet med ett nytt?
1000
Din möjlighet att kommentera är för tillfället avstängd på grund av negativa användarrapporter. Din status granskas av våra moderatorer.
Vänta en minut innan du försöker kommentera igen.
Tack för din kommentar. Observera att alla kommentarer är under behandling tills de godkänts av våra moderatorer. Det kan därför ta lite tid innan inlägget visas på vår hemsida.
 
Aär du säker på att du vill ta bort det här diagrammet?
 
Posta
 
Ersätt det bifogade diagrammet med ett nytt?
1000
Din möjlighet att kommentera är för tillfället avstängd på grund av negativa användarrapporter. Din status granskas av våra moderatorer.
Vänta en minut innan du försöker kommentera igen.
Lägg till diagram till kommentar
Bekräfta blockering

Är du säker på att du vill blockera %USER_NAME%?

Genom att blockera kan du och %USER_NAME% inte se varandras inlägg på Investing.com.

%USER_NAME% lyckades läggas till i din Blockeringslista

Eftersom du precis avblockerat denna person måste du vänta 48 timmar för att kunna förnya blockeringen.

Rapportera den här kommentaren

Jag anser att denna kommentar är:

Kommentar flaggad

Tack!

Rapporten har skickats till våra moderatorer för granskning
Registrera dig med Google
eller
Registrera dig med e-post